[Federal Register Volume 72, Number 124 (Thursday, June 28, 2007)]
[Notices]
[Page 35493]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-12497]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. 2006N-0430]


Agency Information Collection Activities; Announcement of Office 
of Management and Budget Approval; General Licensing Provisions: 
Biologics License Application, Changes to an Approved Application, 
Labeling, Revocation and Suspension, Postmarketing Studies Status 
Reports, and Forms FDA 356h and 2567

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that a 
collection of information entitled ``General Licensing Provisions: 
Biologics License Application, Changes to an Approved Application, 
Labeling, Revocation and Suspension, Postmarketing Studies Status 
Reports, and Forms FDA 356h and 2567'' has been approved by the Office 
of Management and Budget (OMB) under the Paperwork Reduction Act of 
1995.

FOR FURTHER INFORMATION CONTACT: Jonna Capezzuto, Office of the Chief 
Information Officer (HFA-250), Food and Drug Administration, 5600 
Fishers Lane, Rockville, MD 20857, 301-827-4659.

SUPPLEMENTARY INFORMATION: In the Federal Register of February 2, 2007 
(72 FR 5057), the agency announced that the proposed information 
collection had been submitted to OMB for review and clearance under 44 
U.S.C. 3507. An agency may not conduct or sponsor, and a person is not 
required to respond to, a collection of information unless it displays 
a currently valid OMB control number. OMB has now approved the 
information collection and has assigned OMB control number 0910-0338. 
The approval expires on June 30, 2010. A copy of the supporting 
statement for this information collection is available on the Internet 
at http://www.fda.gov/ohrms/dockets.

    Dated: June 21, 2007.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E7-12497 Filed 6-27-07; 8:45 am]
BILLING CODE 4160-01-S